Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Flaherty

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Lung|January 23, 2022
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry CohortJamie L Todd, Megan L Neely, Robert Overton, et al.
Annals of the American Thoracic Society|October 22, 2021
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring OxygenChristopher S King, Kevin R Flaherty, Marilyn K Glassberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2004
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?Kevin R Flaherty, Talmadge E King, Ganesh Raghu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD TrialEric L Matteson, Clive Kelly, Jörg H W Distler, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2016
Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical TrialAdam L Liss, Robin B Marsh, Nirav S Kapadia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosisJanelle Vu Pugashetti, John S Kim, Michael P Combs, et al.
Respiratory Medicine|September 27, 2017
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patientsMargaret L Salisbury, Leslie B Tolle, Meng Xia, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
JAMA Network Open|March 10, 2023
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US AdultsAyodeji Adegunsoye, Elizabeth Freiheit, Emily N White, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Lung|January 23, 2022
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry CohortJamie L Todd, Megan L Neely, Robert Overton, et al.
Annals of the American Thoracic Society|October 22, 2021
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring OxygenChristopher S King, Kevin R Flaherty, Marilyn K Glassberg, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2004
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?Kevin R Flaherty, Talmadge E King, Ganesh Raghu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2022
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD TrialEric L Matteson, Clive Kelly, Jörg H W Distler, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2016
Decreased Lung Perfusion After Breast/Chest Wall Irradiation: Quantitative Results From a Prospective Clinical TrialAdam L Liss, Robin B Marsh, Nirav S Kapadia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 31, 2024
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosisJanelle Vu Pugashetti, John S Kim, Michael P Combs, et al.
Respiratory Medicine|September 27, 2017
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patientsMargaret L Salisbury, Leslie B Tolle, Meng Xia, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
JAMA Network Open|March 10, 2023
Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US AdultsAyodeji Adegunsoye, Elizabeth Freiheit, Emily N White, et al.
Pageof 25